FBLG
FibroBiologics, Inc.
1.40$
+2.3%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | -100.0% | – | – | – | – | – | – | |
| – | +16.1% | +5.4% | +2.2% | – | – | – | – | +12.1% | +1.3% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +35.4% | +24.2% | +1.6% | +24.4% | +11.8% | +31.3% | +14.7% | +36.6% | -71.4% | +270.5% | -43.9% | – | |
| – | +15.3% | +45.9% | -9.7% | -4.9% | +10.1% | +16.8% | -11.0% | -8.2% | -20.3% | +18.0% | +12.3% | – | |
| – | +20.9% | +39.1% | -6.6% | +4.0% | +10.7% | +22.1% | -0.9% | +12.2% | -53.2% | +115.1% | -20.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | +300.0% | +25.0% | +0.0% | +20.0% | -100.0% | – | – | – | -98.0% | +75.0% | – | |
| – | – | – | – | -155.7% | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | -155.7% | – | – | – | – | – | – | – | – | |
| – | – | – | – | -133.7% | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.